New roles for Fc receptors in neurodegeneration-the impact on Immunotherapy for Alzheimer's Disease

New roles for Fc receptors in neurodegeneration-the impact on Immunotherapy for Alzheimer's Disease

There are an estimated 18 million Alzheimer's disease (AD) sufferers worldwide and with no disease modifying treatment currently available, development of new therapies represents an enormous unmet clinical need. AD is characterized by episodic memory loss followed by severe cognitive decline a...

Full description

Bibliographic Details
Main Authors:	Fuller, James P., Stavenhagen, Jeffrey B., Teeling, Jessica L.
Format:	Online
Language:	English
Published:	Frontiers Media S.A. 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139653/

Similar Items

Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies
by: Fuller, James P., et al.
Published: (2015)

Kynurenines, neurodegeneration and Alzheimer’s disease
by: Kincses, Zsigmond Tamas, et al.
Published: (2010)

Immune complex formation impairs the elimination of solutes from the brain: implications for immunotherapy in Alzheimer’s disease
by: Carare, Roxana Octavia, et al.
Published: (2013)

The immunotherapy of Alzheimer's disease
by: Weksler, Marc E
Published: (2004)

Shared Mechanisms of Neurodegeneration in Alzheimer's Disease and Parkinson's Disease
by: Xie, Anmu, et al.
Published: (2014)

The role of type 2 diabetes in neurodegeneration
by: Verdile, Giuseppe, et al.
Published: (2015)

Role of diffuse low-level heteroplasmy of mitochondrial DNA in Alzheimer’s disease neurodegeneration
by: Casoli, Tiziana, et al.
Published: (2015)

Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration
by: Perry, V. Hugh, et al.
Published: (2013)

Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
by: Stopforth, Richard J., et al.
Published: (2016)

Is immunotherapy an effective treatment for Alzheimer's disease?
by: Licastro, Federico, et al.
Published: (2004)

Active immunotherapy options for Alzheimer’s disease
by: Winblad, Bengt, et al.
Published: (2014)

Open questions for Alzheimer’s disease immunotherapy
by: Golde, Todd E
Published: (2014)

Immunotherapy for Alzheimer’s disease: hoops and hurdles
by: Lemere, Cynthia A
Published: (2013)

Correlated Inflammatory Responses and Neurodegeneration in Peptide-Injected Animal Models of Alzheimer's Disease
by: McLarnon, James G.
Published: (2014)

Intracerebral immune complex formation induces inflammation in the brain that depends on Fc receptor interaction
by: Teeling, Jessica L., et al.
Published: (2012)

The relationship of topographical memory performance to regional neurodegeneration in Alzheimer's disease
by: Pengas, George, et al.
Published: (2012)

Immunotherapy for Alzheimer’s disease: past, present and future
by: Spencer, Brian, et al.
Published: (2014)

Amyloid-ß-directed immunotherapy for Alzheimer's disease
by: Lannfelt, L, et al.
Published: (2014)

Alzheimer’s disease and immunotherapy: what is wrong with clinical trials?
by: Kohyama, Kuniko, et al.
Published: (2015)

Characterizing the Role of Brain Derived Neurotrophic Factor Genetic Variation in Alzheimer’s Disease Neurodegeneration
by: Honea, Robyn A., et al.
Published: (2013)

Transport of macrophage Fc receptors and Fc receptor-bound ligands to lysosomes
Published: (1986)

The modular systems biology approach to investigate the control of apoptosis in Alzheimer's disease neurodegeneration
by: Alberghina, Lilia, et al.
Published: (2006)

Epigenetic modifications of chronic hypoxia-mediated neurodegeneration in Alzheimer’s disease
by: Liu, Hui, et al.
Published: (2014)

Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
by: Duan, Yale, et al.
Published: (2012)

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
by: Piotr Lewczuk, et al.
Published: (2018-07-01)

DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes
by: Sykora, Peter, et al.
Published: (2015)

Periodontitis and Cognitive Decline in Alzheimer’s Disease
by: Ide, Mark, et al.
Published: (2016)

Pericyte loss influences Alzheimer-like neurodegeneration in mice
by: Sagare, Abhay P., et al.
Published: (2013)

Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease
by: Lannfelt, Lars, et al.
Published: (2014)

Nicotinic Receptors in Neurodegeneration
by: Posadas, Inmaculada, et al.
Published: (2013)

Inverse correlation between Alzheimer’s disease and cancer: implication for a strong impact of regenerative propensity on neurodegeneration?
by: Li, Jian-Ming, et al.
Published: (2014)

Antibody isotype-specific engagement of Fcγ receptors regulates B lymphocyte depletion during CD20 immunotherapy
by: Hamaguchi, Yasuhito, et al.
Published: (2006)

Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
by: Changyoun Kim, et al.
Published: (2018-08-01)

Neurodegeneration in Alzheimer Disease: Role of Amyloid Precursor Protein and Presenilin 1 Intracellular Signaling
by: Nizzari, Mario, et al.
Published: (2012)

May “Mitochondrial Eve” and Mitochondrial Haplogroups Play a Role in Neurodegeneration and Alzheimer's Disease?
by: Ienco, Elena Caldarazzo, et al.
Published: (2011)

The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease
by: Sato, Naoyuki, et al.
Published: (2015)

Rational engineering of Fc/Fc receptor interactions to improve antibody potency
by: Doberstein, S, et al.
Published: (2003)

Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration
by: Desikan, Rahul S, et al.
Published: (2013)

Impact of the biological definition of Alzheimer’s disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?
by: S. Gauthier, et al.
Published: (2018-05-01)

A novel role for the Fc receptor gamma subunit: enhancement of Fc gamma R ligand affinity
Published: (1996)